Molecular Imaging Market By Techniques 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Molecular Imaging Market
Molecular Imaging Market: By Techniques (PET, SPECT, MRI, CT, Ultra Sound, & Others) & By Geography (Europe, Asia Pacific, North America, Rest of the World)-Forecast (2016-2021)
Report Code : HCR 0318
Updated Date: 25 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Molecular Imaging – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Molecular Imaging – Market Forces
   4.1. Drivers
      4.1.1. Aging Population.
      4.1.2. The adoption and advancement in technologies such as PET/CT
      4.1.3. Non-ionizing imaging techniques
      4.1.4. Growing demand for efficient and accurate imaging system
   4.2. Restraints
      4.2.1 Continuous improvement and innovation in molecular imaging technologies
   4.3. Opportunities
      4.3.1 Emerging economies
      4.3.2 Increase in adoption of Molecular Imaging for newer applications
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Molecular Imaging – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Molecular Imaging Market, By Techniques
   6.1. PET
   6.2. SPECT
   6.3. MRI
   6.4. CT
   6.5. Ultra Sound
   6.6. Others
7. Molecular Imaging Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Molecular Imaging – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Philips
   9.2. Siemens
   9.3. GE Healthcare
   9.4. Cyclopharma
   9.5. Perkin-Elmer
   9.6. Hamamatsu Photonics
   9.7. Scintomics
   9.8. Naviscan
   9.9. Kereos
   9.10. Affibody
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of expert Insights
   10.6. Disclaimer
Molecular imaging market has grown manifold during the course of time, primarily due to increasing demand for detection and monitoring of disease such as cancer and other rare genetic disorders. Globally, aging population, the adoption and advancement in technologies such as PET/CT, non-ionizing imaging techniques and growing demand for efficient and accurate imaging system are the prime growth drivers of molecular Imaging market. In addition, Increase in adoption of Molecular Imaging for newer applications, and emerging economies such as China, India and others, will create new opportunities for molecular imaging market. However, higher cost of the research and development, and continuous improvement and innovation in molecular imaging technologies are the key restraints for molecular imaging market.
Molecular Imaging Market

Geographically USA dominated global Molecular Imaging market, and is projected to have fastest growth, owing to high prevalence of the disorder, technological advancements and high awareness among the patient population. Europe was observed to be the second largest market and one of the leading research destinations for neurological disease diagnosis and treatment. Asia-Pacific and Rest of the World were observed to be the most potential markets for Molecular Imaging diagnosis and treatment market.

This report identifies the Molecular Imaging market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to Global molecular Imaging market.

This report segments global Molecular Imaging market on the basis of techniques and regional market as follows:
  • Molecular Imaging Market By Application: PET, SPECT, MRI, CT, Ultra Sound, & Others
  • This report has been further segmented into major regions, which include detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region. The major countries considered under the Asia-Pacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico

This report identifies all the major companies operating in the global Molecular Imaging market. Some of the major companies’ profiles in detail are as follows:
  • Philips
  • Siemens
  • GE Healthcare Affibody
  • Cyclopharma
  • Perkin-Elmer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports